Latest News

After struggling all year, On's stock got some good news.

What Happened? A number of stocks fell in the afternoon session after investors kept bidding the group lower after last week’s Federal Reserve hike. On Septe...

What Happened? A number of stocks jumped in the afternoon session after seasonal-shopping data pointed to continued consumer demand heading into the holiday ...

SOXX and IYW offer distinct approaches to the technology sector. Here's how the two compare.

The founder of Vanguard recommended a simple approach for buying stocks and building long-term wealth.

The insider's capital commitment signals confidence in the specialty retailer despite the stock's 13% decline over the past year.

Compass Pathways (NASDAQ:CMPS) expects to complete its new drug application submission for COMP360, its investigational psilocybin treatment for treatment-resistant depression, in the fourth quarter, with a potential U.S. launch in the first half of 2027, executives said at the Morgan Stanley Global

What is the first investing decision? It has nothing to do with picking stocks.

Arm Holdings shares jumped 17% on reports of a Meta custom-chip partnership and a $2 billion AI processor target, though elevated valuation multiples and foundry supply constraints temper near-term upside.

Pop toy maker Here posts 94% growth amid China retail headwinds.

Orders returned to growth as retail strength offset North America contract softness.

Record store expansion and Mega Hub growth offset DIY weakness in fiscal 2026.

See how these two popular ETFs stack up on risk, performance, and fees.

This early mover in the quantum market still has a bright future.

These tech stocks are growing at an impressive pace, and they are significantly cheaper than Palantir.

Of the 14 U.S.-listed companies now worth $1 trillion or more, 11 have been recommended by Team Rule Breakers or David Gardner.

Wall Street doesn't appear to be giving Medtronic credit for its improving results.

The insider purchase signals confidence despite the stock's 54% decline over past year.

A Comprehensive Guide to Data Consistency, Brand Authenticity, and Regional Search VisibilityIn today’s digital-first business environment, local discovery

Oura's IPO targets a $12.8B-$14.1B valuation, pricing shares at $40-$44 ahead of its Nasdaq debut, backed by Eli Lilly interest and strong subscription revenue growth.

VOOG targets large-cap tech giants, while IWO offers broader exposure to over 1,000 small-cap stocks. Here's how the two stack up.

Salesforce offers a more attractive valuation and proven cash generation. ServiceNow offers faster growth and a more defensible market position.

"Sweet" is one of the most subjective words in fragrance reviewing. What reads as pleasantly warm to one person reads as cloying to another, and Vanille Ma